Tumor glycolytic profiling through 18F-FDG PET/CT predicts immune checkpoint inhibitor efficacy in advanced NSCLC
Saulo Brito Silva Carlos Wagner Souza Wanderley; José Flavio Gomes Marin; Mariana Petaccia de Macedo; Ellen Caroline Toledo do Nascimento; Fernanda Fronzoni Antonacio; Caroline Sales Figueiredo; Mateus Trinconi Cunha; Fernando de Queiroz Cunha; Gilberto de Castro Junior
Therapeutic Advances in Medical Oncology London v. 14, art. 17588359221138386, p. 1-13, 2022London 2022
Localização: FMRP - Fac. Medicina de Ribeirão Preto (pcd 3153548 Acervo Digital )(Acessar)